Home / Import refusals / SCS-1785217-3/11/2

FDA Import Refusal SCS-1785217-3/11/2 — Teva Canada Limited

Teva Canada Limited — FEI 3002807756

The FDA refused shipment SCS-1785217-3/11/2 from Teva Canada Limited (Canada) on January 16, 2024. The refused product falls under Drugs and Biologics — PANTOPRAZOLE SODIUM. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
January 16, 2024
Country
Canada
Product Category
Drugs and Biologics
Product Code
62TCA07 PANTOPRAZOLE SODIUM
Charges
75

Recent inspections

  • 1224785 (NAI Fri Nov 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1107481 (VAI Fri Oct 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1038516 (NAI Thu Dec 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 961307 (VAI Fri Feb 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 838128 (NAI Fri May 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-0020981-1/10003/1 (Wed Dec 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8576098-3/23/1 (Wed Jun 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6451070-6/11/1 (Wed Mar 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8217021-6/11/1 (Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2680545-9/11/4 (Fri Aug 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources